Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMSX47Q)

Drug Name
Phenylpyrrolidinone derivative 4 Drug Info
Synonyms PMID27646439-Compound-8
Cross-matching ID
PubChem CID
118373037
TTD Drug ID
DMSX47Q

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting PRKR-like endoplasmic reticulum kinase (PERK)
Drug Name Drug ID Indication ICD 11 Highest Status REF
HC-5404 DMKFZW5 Breast cancer 2C60-2C65 Phase 1 [2]
Tricyclic isoxazoloquinazoline derivative 2 DMH4TY1 N. A. N. A. Patented [1]
Tricyclic isoxazoloquinazoline derivative 4 DM8VIM4 N. A. N. A. Patented [1]
Tricyclic isoxazoloquinazoline derivative 3 DML2PWF N. A. N. A. Patented [1]
Phenylpyrrolidinone derivative 3 DMPZKQN N. A. N. A. Patented [1]
Indoline derivative 6 DMU5KWC N. A. N. A. Patented [1]
Tricyclic isoxazoloquinazoline derivative 1 DM6QSND N. A. N. A. Patented [1]
Phenylpyrrolidinone derivative 1 DMPAI5C N. A. N. A. Patented [1]
Phenylpyrrolidinone derivative 5 DMZSTLH N. A. N. A. Patented [1]
Indoline derivative 3 DM20YBJ N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
PRKR-like endoplasmic reticulum kinase (PERK) TT5OU0D E2AK3_HUMAN Inhibitor [1]

References

1 Protein kinase R(PKR)-like endoplasmic reticulum kinase (PERK) inhibitors: a patent review (2010-2015).Expert Opin Ther Pat. 2017 Jan;27(1):37-48.
2 Clinical pipeline report, company report or official report of HiberCell